| Medical and Health Sciences | 2021-2025 | 377 | NP 1 | 99.92 |
| Biological Sciences | 2021-2025 | 229 | NP 1 | 99.77 |
| Infectious Diseases | Lifetime | 694 | NP 1 | 96.98 |
| Virology | Lifetime | 357 | NP 1 | 90.96 |
| Parasitology | Lifetime | 777 | NP 1 | 75.57 |
| Veterinary Science and Animal Health | Lifetime | 938 | NP 1 | 70.70 |
| Virology | 2021-2025 | 1 | NP 1 | 99.77 |
| Infectious Diseases | 2021-2025 | 37 | NP 1 | 99.50 |
| Public, Environmental and Occupational Health | 2021-2025 | 75 | NP 1 | 99.39 |
| Epidemiology | 2021-2025 | 90 | NP 1 | 99.48 |
| COVID-19 Clinical Research Studies | Lifetime | 545 | NP 1 | 97.94 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 571 | NP 1 | 98.16 |
| Poxvirus research and outbreaks | Lifetime | 92 | NP 1 | 97.53 |
| Bacillus and Francisella bacterial research | Lifetime | 144 | NP 1 | 97.29 |
| COVID-19 epidemiological studies | Lifetime | 851 | NP 1 | 95.18 |
| Viral Infections and Outbreaks Research | Lifetime | 651 | NP 1 | 94.77 |
| SARS-CoV-2 detection and testing | Lifetime | 714 | NP 2 | 91.40 |
| Zoonotic diseases and public health | Lifetime | 582 | NP 1 | 93.25 |
| COVID-19 diagnosis using AI | Lifetime | 929 | NP 1 | 88.29 |
| Travel-related health issues | Lifetime | 822 | NP 6 | 80.37 |
| Herpesvirus Infections and Treatments | 2021-2025 | 1 | NP 1 | 99.67 |
| Viral Infections and Outbreaks Research | 2021-2025 | 1 | NP 1 | 99.35 |
| Bacillus and Francisella bacterial research | 2021-2025 | 1 | NP 1 | 99.58 |
| Viral Infections and Vectors | 2021-2025 | 5 | NP 1 | 99.60 |
| Poxvirus research and outbreaks | 2021-2025 | 2 | NP 1 | 99.64 |
| Virology and Viral Diseases | 2021-2025 | 2 | NP 1 | 99.14 |
| Mosquito-borne diseases and control | 2021-2025 | 41 | NP 1 | 99.02 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 344 | NP 1 | 98.48 |
| Zoonotic diseases and public health | 2021-2025 | 37 | NP 1 | 96.76 |
| COVID-19 Clinical Research Studies | 2021-2025 | 643 | NP 1 | 97.25 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 403 | NP 2 | 93.30 |
| COVID-19 epidemiological studies | 2021-2025 | 574 | NP 1 | 93.37 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 540 | NP 1 | 93.42 |
| SARS-CoV-2 detection and testing | 2021-2025 | 684 | NP 1 | 89.80 |
| Influenza Virus Research Studies | 2021-2025 | 490 | NP 1 | 90.50 |
| Vector-Borne Animal Diseases | 2021-2025 | 352 | NP 1 | 88.83 |
| Yersinia bacterium, plague, ectoparasites research | 2021-2025 | 182 | NP 1 | 83.26 |
| Rabies epidemiology and control | 2021-2025 | 312 | NP 2 | 81.64 |
| Neonatal and Maternal Infections | 2021-2025 | 941 | NP 1 | 57.51 |
| Legionella and Acanthamoeba research | 2021-2025 | 936 | NP 2 | 26.43 |
